💰 Funding & strategic moves
CMR Surgical (UK) — Surgical robotics. Transaction: proposed strategic preferred equity investment | Amount: approximately $400 m / £300 m | Investor: Stryker . The agreement includes exclusive US sales agency rights for the Versius portfolio and an option for Stryker to acquire the remaining equity. The transaction remains subject to regulatory approvals and customary closing conditions. Takeaway: strategic capital can combine financing, distribution and a potential acquisition pathway in one agreement. Date: Oct. 12.
OMass Therapeutics (UK) — Small-molecule drug discovery and development. Round: Series C | Amount: $310 m / £230 m. Co-leads: Bain Capital Ventures (BCV) Life Sciences, Forbion and Novo Holdings . Others include Janus Henderson Investors , SV Health Investors , Jefferson Life Sciences and existing shareholders. Proceeds support Phase 2 development of OMS1620 and initial clinical data for its SLC15A4 programme. Takeaway: specialist life-sciences syndicates continue to finance substantial clinical milestones in European university spinouts. Date: Oct. 15.
Salience Labs (UK) — Photonic networking for AI data centres. Round: Series B | Amount: $125 m. Lead: Bullhound Capital . Others include AMD Ventures , Intel Capital , SBI Equity Group , Hudson River Trading , British Business Bank and existing investors. Funding supports optical switching deployment, manufacturing expansion and a larger US presence. Takeaway: moving data efficiently between GPUs is attracting specialist investment alongside compute itself. Date: Oct. 14.
Skeleton Technologies (EE) — High-power energy systems for AI infrastructure. Transaction: Siemens -led strategic investment | Amount: described by the company as a nine-digit round; exact figure undisclosed | Company-reported valuation: above $1 b. Funding supports US manufacturing and R&D expansion. Its separate plan to invest more than $200 m in expansion is a spending commitment, not the disclosed round size. Takeaway: power stability offers an industrial route into AI infrastructure demand. Date: Oct. 14.
1KOMMA5° (DE) — Distributed energy management through Heartbeat AI. Financing: approximately €70 m, with the company describing an initial volume above €70 m | Pre-money valuation: $1.35 b. Lead: b2venture . New investor: Marunouchi Innovation Partners . Existing participants include CalSTRS , eCapital Corp. , G2 Venture Partners and Eurazeo . The company plans more than €100 m of Heartbeat AI investment in 2027, combining financing and operating cash flow. Takeaway: energy software can expand the value of an installed hardware base through optimisation and electricity-market participation. Date: Oct. 13.
duvo.ai (CZ-founded; international expansion) — AI agents for enterprise operations. Round: Series A | Amount: $32 m | Reported total funding: $48 m. Lead: BALDERTON CAPITAL (UK) LLP . Others: Index Ventures , Northzone and Credo Ventures . The platform runs approved processes across existing enterprise systems, initially targeting retail and consumer goods. Takeaway: integration, approvals and repeatable workflows are becoming central to enterprise AI underwriting. Date: Oct. 14.
Ubitium (DE) — Reconfigurable processors for physical AI. Round: Seed | Amount: $14 m | Total seed funding: $18 m. Lead: Ibex Investors. Others: OpenOcean , KBC Focus Fund , Runa Capital , Inflection Point Ventures and Quantum Systems co-founder Florian Seibel , investing personally. The company reports working first silicon; commercial evaluation units are planned for 2027. Takeaway: combining sensing, inference and control on one architecture could reduce integration costs for autonomous machines. Date: Oct. 13.
Ramp (US) — Financial operations and spend management. Financing: primary equity | Amount: $1.85 b | Announced valuation: $60 b. Lead: Dragoneer Investment Group . Co-leads: Thrive Capital , Founders Fund , Sands Capital and Avenir Growth . Ramp reports more than $2 b in annualised revenue and positive cash flow; this revenue measure includes interchange, subscriptions, interest and other revenue, net of customer incentives. Takeaway: established transaction platforms have a distribution advantage when adding AI automation and cost controls. Company confirmation: Oct. 15, following earlier reporting.
🎯 Players recognition & performance
Sprints (UK / Europe) — Reported final close of Fund V at its €725 m hard cap, around 40% larger than its predecessor. The firm invests in European growth technology businesses. Takeaway: established European growth managers can still attract larger vehicles, although an individual fund close does not establish a broad fundraising recovery. Reported: Oct. 15.
Jolt Capital / CDP Venture Capital SGR (FR / IT) — CDP Venture Capital committed to Jolt Capital V; the commitment amount was not disclosed. The vehicle previously reached a €600 m first close and has a €1.1 b hard cap. It targets growth-stage European deeptech, including semiconductors, medical devices and applied AI. Takeaway: national fund-of-funds programmes can connect domestic companies with international specialist managers. Date: Oct. 13.
Pear VC (US) — Closed Fund V at $333 m, bringing firmwide assets under management above $1.1 b. Most of the vehicle is intended for new pre-seed and seed investments, with follow-on reserves and a planned deployment period of roughly two and a half years. Takeaway: early founder access and focused deployment remain viable strategies alongside the industry's larger funds. Date: Oct. 14.
Adams Street Partners (US / global) — Announced AVNGR , an evergreen venture and growth fund focused primarily on secondaries and growth co-investments. The announcement cites $363.5 m in anchor-funded net assets as of July 31; broader availability is planned for Dec. 1. It intends to offer limited quarterly repurchases. Takeaway: evergreen structures widen access, while repurchase limits remain important to understanding liquidity. Announcement: Oct. 13.
UK venture market — Q3 performance — HSBC Innovation Banking and Dealroom.co report $6.9 b raised across 31 new UK venture funds, a quarterly record. Index Ventures accounted for just over half. UK startups and scaleups separately raised $6.1 b, with 11 large rounds contributing $3.5 b. Takeaway: fundraising strength and financing availability are unevenly distributed; manager concentration and round size matter alongside totals. Data period: Q3 2026.
🏛️ Macroeconomic & regulatory developments
EU company law and capital-market integration (EU) — European Investors Council leaders called for negotiations on key competitiveness measures, including the 28th company-law regime and capital-market integration and supervision, to conclude by year-end. These are political priorities for ongoing negotiations, not confirmation that the legislation has taken effect. Why it matters: a more integrated company-law and financing framework could reduce friction for European scaleups and their investors. Date: Oct. 15–16.
Startup Ireland (IE) — Enterprise Ireland launched an initiative targeting 1,000 new startups and a 20% increase in the number reaching €1 m in turnover. Measures include a National Startup Hub, an AI accelerator and a National Company Accelerator offering €100,000 investments to participants. Why it matters: coordinated founder support can improve investment readiness and international market access. The €100,000 investment relates to accelerator participants, rather than a guaranteed award to every targeted startup. Date: Oct. 13.
👥 Leadership watch
Hamilton Lane (US / global) — Named Hartley Rogers Co-CEO alongside Juan Delgado-Moreira ; Erik Hirsch became Executive Co-Chairman, focused on strategic growth initiatives. Why it matters: the leadership allocation gives investors a clearer view of responsibility for operating management and longer-term partnerships, acquisitions and technology strategy. Announced: Oct. 15; appointment effective Oct. 12.
Pear VC (US) — Promoted Arash Afrakhteh , Ajay Kamat and Shravan Reddy to General Partner alongside Fund V. Their investment coverage includes enterprise technology, consumer and fintech, AI infrastructure and robotics. Why it matters: internal succession expands investment leadership while preserving the firm's early-stage focus. Date: Oct. 14.
DUVO (international) — Mike Green joins from Databricks as Chief Commercial Officer; former Kmart president Spencer Insolia recently joined as Managing Director, US. Both were highlighted with the Series A announcement. Why it matters: commercial leadership and sector experience are becoming important execution milestones as European-founded enterprise AI companies expand in the US. Announced: Oct. 14.
📈 Market trends
AI infrastructure investment extends into networking and electricity. Salience Labs and Skeleton address different constraints on AI deployment: moving data between processors and managing rapid power fluctuations. Our reading: manufacturing execution, customer qualification and measurable system economics deserve as much attention as technical benchmarks.
Commercial access is part of the financing proposition. CMR's proposed Stryker alliance combines capital with US distribution; Duvo is pairing its raise with senior commercial hires. Our reading: the ability to reach buyers and implement products can materially change the investment case for technically strong companies.
Record fundraising can coexist with concentration. The UK's Q3 figures show both record fund formation by value and a heavy contribution from one manager, while company financing was also led by large rounds. Our reading: investors should track capital by manager, stage and sector before treating headline growth as evidence that financing conditions improved across the market.
🏆 Visontio Spotlight — Companies to watch
- Salience Labs (UK) — Watch manufacturing yields, customer qualification and conversion from optical-switch demonstrations into repeat orders. The next investment milestone is commercial delivery at scale.
- Skeleton Technologies (EE) — Watch US manufacturing execution, customer deployments and independently demonstrated power-system economics.
- Ubitium (DE) — Watch its planned 2027 evaluation units, developer adoption and evidence that one architecture can meet demanding sensing and control workloads economically.
- OMass Therapeutics (UK) — Watch clinical execution, safety and efficacy data, and progress against the milestones financed by its Series C.
- Visontio (AT) — An AI-native Investor OS mapping & tracking capital flows to unveil new risk types accros the capital supply chain. The Fund ERP is bringing sourcing, KPI data, benchmarking, portfolio monitoring and investment workflows into one governed workspace. The opportunity: turn fragmented information into auditable investment decisions.
Content generated by the Visontio AI engine.
